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Abstract
Background: Although the use of radial endobronchial ultrasound (R-EBUS)
with a guide sheath has shown improved diagnostic capability in peripheral pul-
monary lesions, its utility is still low due to variable performance. To overcome
its limitation, we evaluated the feasibility and efficacy of R-EBUS combined with
transbronchial biopsy (TBB) under fluoroscopic guidance.
Methods: We retrospectively reviewed medical records of 74 patients with non-
small cell lung cancer (NSCLC) who underwent R-EBUS combined with TBB or
TBB alone as a diagnostic technique. Subjects were grouped according to the
diagnostic modality used (R-EBUS combined with TBB vs. TBB alone). Each
group was matched for age, sex, and location of the biopsy. The chi-square test
and paired t-test were used to compare characteristics and identify factors that
affected the diagnostic yield.
Results: The mean age of the study cohort was 67.4  12.8 years, with
21 (56.8%) men and 16 (43.2%) women in each group. The lesion size was signif-
icantly smaller in the R-EBUS group (23.6 vs. 33.9, P < 0.001). The diagnostic
yield with the combined use of R-EBUS and TBB (27/37, 72.9%) was significantly
higher than that with standard TBB alone (22/37, 59.4%). Lung lesions with a
positive bronchus sign were associated with a higher diagnostic yield (odds
ratio = 3.52 [1.17–10.62]; P = 0.025).
Conclusions: The combination of R-EBUS with TBB resulted in a higher diag-
nostic yield than either technique alone. Thus, the addition of R-EBUS biopsy
would be helpful to improve the diagnostic yield of TBB.
Key points
Significant findings of the study: The combination of R-EBUS with TBB under
fluoroscopic guidance improved the diagnostic yield of PPLs compared to TBB alone.
A tissue diagnosis was more likely in pulmonary lesions with the air-bronchus sign.
What this study adds: The use of R-EBUS could help improve the low diagnos-
tic yield of TBB under fluoroscopic guidance without increasing the incidence of
complications.
Introduction
Lung cancer represents a major worldwide disease burden.1
According to Global Cancer Statistics 2018, lung cancer is a
leading cause of newly diagnosed cancer and deaths across
20 regions of the world.2 Despite the introduction of
preventive strategies such as tobacco control, new diagnostic
modalities, and therapeutic agents, the incidence of cancer
and cancer-related mortality rates are expected to increase.3
Recently, with the introduction of low-dose helical com-
puted tomography (CT) for lung cancer screening, the
detection rate of peripheral pulmonary lesions (PPLs) has
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increased.4 Thus, there has been an increasing need to
acquire histopathological specimens from PPLs. In addi-
tion to improving the survival rate through the early diag-
nosis of lung cancer, histopathology of PPLs also facilitates
decision-making regarding the use of new therapeutic
agents such as immunotherapy.5
Conventionally, transbronchial biopsy (TBB) under fluo-
roscopic guidance has been widely used in the diagnosis of
PPLs since the 1970s.6 Performing biopsies under real-time
imaging of the lesions is a major advantage of TBB. How-
ever, determining the three-dimensional location of the
lesion using only a two-dimensional fluoroscopic image
remains a challenging task. In particular, when the target
area of the biopsy overlaps with other pulmonary struc-
tures, it is difficult to determine the precise location. More-
over, the diagnostic yield of TBB varies from 14% to 75%,
which is lower than that of transthoracic needle
aspiration.7,8
Approximately 20 years ago, advanced bronchoscopic
modalities, such as endoscopic navigation bronchoscopy
(ENB), thin bronchoscopy, and radial endoscopic ultra-
sound (R-EBUS), were introduced to overcome the short-
comings of these conventional techniques.9,10 The 2013
American College of Chest Physicians guidelines recom-
mend radial EBUS as an alternative to conventional bron-
choscopy if the equipment and expertise are available.11
R-EBUS using thin bronchoscopy has a higher diagnos-
tic yield (51%–92%) and lower complication rate than con-
ventional bronchoscopy.12,13 Under ultrasound guidance,
the operator can perform a biopsy while observing the PPL
in real-time. However, the equipment required for this
procedure is expensive. Furthermore, the ability to accu-
rately target the lesion may be highly dependent on the
skills and knowledge of bronchial anatomy of the
operator.14–16
Therefore, the purpose of this study was to determine
the improved diagnostic capability of R-EBUS when com-
bined with conventional TBB in the diagnosis of PPLs.
Methods
Study design and patient selection
This study was conducted at the Severance Hospital, Seoul,
Korea. A retrospective review of electronic medical records
was conducted on consecutive lung cancer patients at the
pulmonary division of the hospital from August 2017 to
November 2018. During the study period, TBB was per-
formed in 432 lung cancer patients. Among this cohort,
37 patients underwent TBB combined with R-EBUS
biopsy. They were matched with the remaining 395 patients
who underwent TBB under fluoroscopic guidance alone
according to age, sex, smoking status, and characteristics of
the lesion, including location, type, and size. Among the
395 patients, we selected cases highly suspected of lung
cancer on chest CT to reduce the possibility of including
those with benign diseases. We also excluded cases with
signs of infection such as fever, hypotension, leukocytosis,
or elevated C-reactive protein levels. Even if the study sub-
jects’ bronchoscopic biopsy revealed a benign pathology,
they were followed up for six months. The diagnosis of
lung cancer was made by using follow-up images, multi-
disciplinary consultation, as well as another modality of
biopsy such as CT-guided needle aspiration biopsy or sur-
gical biopsy.
Ethics approval
This study was approved by the institutional review board
of the Severance Hospital (Approval number
4–2019-1106).
Bronchoscopic procedures
Bronchoscopy was performed by six fellowship trainees of
the pulmonology division of our institution. Each fellow-
ship trainee underwent a training period of 4–15 months
and had performed a minimum of 100 TBBs. Both TBB
and R-EBUS were performed under the supervision of an
expert faculty member with previous experience with the
procedure. A thin bronchoscope (EB-P290; Olympus) with
a 4.2 mm outer diameter and a 2.0 mm working channel
was used in both groups. EBUS was performed using an
endoscopic ultrasound system (UM-S20-17S; Olympus,
Japan), equipped with a 20-MHz mechanical radial-type
probe. Prior to sedation, topical anesthesia of the larynx
was applied for 5 minutes using a 2% lidocaine spray. To
perform bronchoscopy under deep sedation, intravenous
midazolam (2–5 mg depending on patient’s bodyweight)
and fentanyl (50 mcg) were administered. After insertion
of the bronchoscope through the mouth, the trachea and
whole bronchi were first inspected. The bronchoscope was
placed on the segmental bronchus close to the PPL. A
radial probe was then inserted through the working chan-
nel to advance into the segmental bronchus near the PPL
to localize the lesion. This process was completed under
fluoroscopic guidance to facilitate visualization. After local-
ization using EBUS, the probe was removed with the guide
sheath remaining on the peripheral lesion. Subsequently,
biopsy forceps (Olympus, 1.5 mm portion diameter) were
introduced via the guide sheath to perform pathological
examination. After performing four biopsies using R-
EBUS, both the radial probe and guide sheath were
removed via the working channel. The target site was
located using typical radial EBUS images that have previ-
ously been described for solid nodules, and the blizzard
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sign for nodules demonstrating ground-glass opacity
(GGO).17 A representative case of R-EBUS is shown in
Fig 1. Afterwards, four biopsies were done only after con-
firming the approximate placement of the TBB forceps
(Olympus, 1.9 mm portion diameter) to the PPL under
fluoroscopy. With regard to the TBB group, only TBB was
completed eight times under fluoroscopic guidance without
prior R-EBUS biopsy.
Complications
Patients were hospitalized for more than two days for the
bronchoscopy procedure and monitored for complications
during the hospital stay. They were specifically monitored
for the development of hemoptysis, pneumothorax, fever,
desaturation, chest pain, and respiratory failure. In-hospital
mortality among the study subjects was also recorded. Chest
radiography was performed within three hours after the pro-
cedure to check for possible pneumothorax and TBB-related
bleeding. Desaturation was defined as a drop in oxygen satu-
ration to <95% during or after the procedure.
Statistical analysis
Data analysis was completed on demographic and clinico-
pathologic variables. Descriptive statistics are reported as
the mean  standard deviation, and categorical variables
as frequencies and proportions. Differences between the
standard TBB and R-EBUS with TBB groups were analyzed
using the Student’s t-test, chi-square test, or Fisher’s exact
test. We performed univariate and multivariate logistic
regression analyses to assess the significance of lesion char-
acteristics as an independent predictive factor for diagnos-
tic yield. Statistical analyses were performed using the IBM
SPSS software, version 25.0 (IBM Co., Armonk, NY, USA).
Results
Characteristics of study subjects and
procedures
The study cohort consisted of 37 patients in each group,
including 21 (56.8%) men and 16 (43.2%) women. The mean
age of the study cohort was 67.4  12.8 years. Comorbidities
Figure 1 Case of a 74-year-old
man with a consolidation in the
right lower lobe.(a) Chest X-ray
showing consolidation at the right
lower lobe. (b) Computed tomog-
raphy (CT) scan showing a 38 mm
peripheral lung mass. (c) Radial
probe endobronchial ultrasound
(R-EBUS) in the lateral basilar seg-
ment of the right lower lobe
revealing a mixed blizzard sign
containing a heterogeneous
acoustic shadow with hyperechoic
dots, linear arcs, and vessels. (d)
Fluoroscopic image during trans-
bronchial biopsy through a guide
sheath.
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such as hypertension, diabetes, and tumor marker (carcino-
embryonic antigen and Cyfra 21–1) levels were not signifi-
cantly different between the two groups. The mean duration
of the bronchoscopy procedure was 42.9  16.4 minutes in all
patients. The mean procedural time was longer in the
R-EBUS-TBB group than in the TBB group (47.6  15.3
vs. 38.1  16.2 minutes); however, the difference was not sta-
tistically different (P = 0.743) (Table 1).
Radiographic characteristics of pulmonary
lesions
Radiographic characteristics of the target lesions are pres-
ented in Table 1. Most lesions were located in the left upper
lobe (22, 29.7%) and were solid in appearance (53, 71.6%).
The air-bronchus sign was seen in 32 (43.2%) cases, with no
significant difference between the two groups (P = 0.241).
The mean distance from the pleura to the lesion also
showed no significant difference between two groups
(14.8  14.4 mm vs. 10.3  10.5 mm, P = 0.102). The mean
size of the pulmonary lesion was 28.7  13.2 mm, which
was smaller in the R-EBUS-TBB group than in the TBB
group (23.6  7.6 vs. 34.5  15.5 mm, P < 0.001).
Factors associated with diagnostic yield
In the R-EBUS-TBB group, diagnostic yield of R-EBUS
and TBB were 40.5% and 54%, respectively. When we mer-
ged both biopsy results, overall 27 patients (72.9%) were
diagnosed with lung cancer. This result was much higher
than the diagnostic yield of the TBB-only group (59.4%).
The diagnostic rate of TBB was slightly higher than that of
the R-EBUS-TBB group (Fig. 2). Among the variables stud-
ied, lung lesions with the air-bronchus sign were associated
with a higher diagnostic yield (odds ratio = 3.52 (1.17–10.62);
P = 0.025) (Table 2).
Table 1 Patient and lesion characteristics
Variable All subjects Standard TBB R-EBUS-TBB P-value
Male sex 42 (37.8) 21 (56.8) 21 (56.8) 1.000
Age 67.4  12.8 67.3  12.8 67.5  13.0 0.808
Ever-smoker 28 (56.7) 21 (56.8) 17 (45.9) 0.486
Comorbidities
Hypertension 27 (36.4) 14 (37.8) 13 (35.1) 1.000
Diabetes 12 (16.2) 8 (21.6) 4 (10.8) 0.345
Old CVA 2 (2.7) 1 (2.7) 1 (2.7) 1.000
Old Tbc 10 (13.5) 7 (18.9) 3 (8.1) 0.308
COPD 6 (8.1) 3 (8.1) 3 (8.1) 1.000
Asthma 4 (5.4) 2 (5.4) 2 (5.4) 1.000
Other malignancies 16 (21.6) 9 (24.3) 7 (18.9) 0.778
Tumor markers
CEA 26.4  83.8 35.7  95.7 19.2  73.9 0.447
Cyfra 21–1 3.0  1.9 2.9  1.4 3.1  2.2 0.856
Procedure duration (minutes) 42.9  16.4 38.1  16.2 47.6  15.3 0.743
Location of PPL(s) 1.000
RUL 16 (21.6) 8 (21.6) 8 (21.6)
RML 6 (8.1) 3 (8.1) 3 (8.1)
RLL 20 (27.0) 10 (27.0) 10 (27.0)
LUL 22 (29.7) 11 (29.7) 11 (29.7)
LLL 10 (13.5) 5 (13.5) 5 (13.5)
Nodule type 0.193
Solid 53 (71.6) 26 (70.3) 27 (73.0)
Subsolid 15 (20.2) 6 (16.2) 9 (24.3)
GGO 6 (8.1) 5 (13.5) 1 (2.7)
Air-bronchus sign 32 (43.2) 18 (48.6) 14 (37.8) 0.241
Size, mean (mm) 28.7  13.2 34.5  15.5 23.6  7.6 < 0.001*
< 20 20 (27.0) 7 (18.9) 13 (35.1)
20–30 28 (37.8) 11 (29.7) 17 (45.9)
> 30 26 (35.1) 19 (51.4) 7 (18.9)
Pleural distance (mm) 12.5  12.7 10.3  10.5 14.8  14.4 0.102
*Significant differences (P < 0.05). CEA, carcinoembryonic antigen; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CVA, cere-
brovascular accident; GGO, ground-glass opacity; LLL, left lower lobe; LUL, left upper lobe; RLL, right lower lobe; RML, right middle lobe; RUL, right
upper lobe; TBB, transbronchial biopsy; Tbc, tuberculosis.
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Bronchoscopic diagnosis
The bronchoscopic diagnosis of study subjects is pres-
ented in Table 3. Of the 74 patients, 49 (66.2%) were
diagnosed with malignancy. Among the diagnosed cases,
adenocarcinoma (49, 58.1%) was the most common.
Benign conditions such as nonspecific inflammation,
granuloma, and pneumonia were diagnosed in six
patients (8.1%). We were unable to obtain meaningful
results from 11 (29.7%) cases in the TBB group and
eight (21.6%) cases in the R-EBUS-TBB group because
the biopsy forceps were unable to approach the PPL, or
insufficient tissue sample collection.
Complications after the procedure
Overall, complications were encountered in seven patients
(9.4%). Desaturation (6, 8.1%) was the most common
complication, following by chest pain (5, 6.7%), pneumo-
thorax (3, 4.0%), and hemoptysis (3, 4.0%). There were
no life-threatening complications such as respiratory fail-
ure and no in-hospital mortality in the study subjects.
There was no significant difference in the complications
between the TBB and R-EBUS-TBB groups (P = 0.317)
(Table 4).
Discussion
The present study revealed that combining R-EBUS with
conventional TBB resulted in a higher diagnostic yield than
TBB alone. Even though the lesion size was smaller in the
R-EBUS-TBB group, the diagnostic yield was higher. Ultra-
sonographic guidance allowed the confirmation of the
exact location of the lesion, thereby enabling the precise
performance of biopsy. Furthermore, the acquisition of
larger specimens was possible when TBB was combined
with R-EBUS.
There are several benefits and disadvantages of TBB
under fluoroscopic guidance. Real-time imaging with fluo-
roscopy enables visual feedback to the operator, allowing
precise guidance during biopsy. However, some studies
have reported that fluoroscopy does not improve specimen
acquisition because it only provides two-dimensional
images. In addition, there are concerns regarding radiation
exposure to the operator.18,19
Due to the limitations of conventional bronchoscopy,
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Figure 2 Schematic figure of diagnostic yield in two groups. * R-EBUS, radial probe endobronchial ultrasound; TBB, transbronchial biopsy.
Table 2 Univariate and multivariate analysis for predictors of diagnostic yield
Univariate analysis Multivariate analysis
Variable OR (95% CI) P-value OR (95% CI) P-value
Solid nodule 0.49 (0.15–1.56) 0.223
Nodule size ≥30 mm 0.72 (0.27–1.95) 0.526
Air-bronchus sign 3.30 (1.21–9.00) 0.017 3.52 (1.17–10.62) 0.025*
Cavitation 0.82 (0.21–3.24) 0.783
Pleural distance >20 mm 0.65 (0.18–2.34) 1.000
R-EBUS arm 1.27 (0.48–3.33) 0.624
*Significant differences (P < 0.05). CI, confidence interval; OR, odds ratio; R-EBUS, radial endobronchial ultrasound.
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biopsy, including R-EBUS, electromagnetic navigation
bronchoscopy, and thin bronchoscopy, has been
reported. The overall diagnostic yield is reported to be
53.0%–82.4% using R-EBUS. Some studies have reported
increased diagnostic rates of up to 84.4% when ENB and
R-EBUS were combined.18,20 A combination of different
bronchoscopic modalities is expected to increase the
diagnostic yield. However, few studies have evaluated an
increase in the diagnostic yield with R-EBUS combined
with standard TBB.
Recently, a multicenter prospective study compared the
diagnostic yield of standard TBB with that of R-EBUS-
TBB21 and reported poor diagnostic yield despite combin-
ing R-EBUS with standard TBB. This result may be
explained by a high proportion of benign diseases among
this study cohort. According to a recent study by Kim
et al. there was no significant difference between combined
use of R-EBUS and TBB and TBB alone in the diagnosis of
benign lung disease.22 It is difficult to determine the precise
location of benign inflammatory lesions compared with
that of cancer lesions usually accompanied by solid or
subsolid nodules, which are typically clearly visualized on
EBUS images. Thus, the presence of benign lung diseases
among a study cohort may mask the benefits of R-EBUS in
identifying lung cancer. In the present study, we only
enrolled patients with a high level of suspicion for lung
cancer in CT images. Therefore, the proportion of patients
with benign diseases was lower than that in the previous
study, which may have contributed to a higher diagnostic
yield with the concomitant use of R-EBUS.
The fellowship trainees who performed the procedure in
our study had a minimum experience of 5–20 months in
the pulmonology department and had performed at least
100 fluoroscopy-guided TBBs. Although the bronchoscopy
skills of these operators were adequate to perform
fluoroscopy-guided TBB, they were less experienced with
R-EBUS.23 Because an understanding of the detailed three-
dimensional anatomical structure is essential, pathologic
biopsy with R-EBUS is a procedure that is challenging to
master. A previous study had reported that over three years
of experience or performance of 400 procedures is required
to be able to achieve consistent success with R-EBUS-
guided TBB.24 This means that even if the procedures are
conducted under the instruction of a supervisor, the fellow-
ship trainees may experience considerable difficulty in the
process. However, our results showed a marked increase in
the diagnostic yield with the combined use of R-EBUS and
fluoroscopic biopsy even though the examiners had not
fully mastered their skills. This relative success may be
attributed to the availability of guidance using fluoroscopy,
which helped minimize mislocation of the radial probe by
allowing visualization of the target anatomic location.
Hence, in a training institution like our hospital, we expect
that the combined use of the two modalities will have edu-
cational benefits as well.
The overall complication rate in the present study was
similar to the previously reported complication rate of
TBB25 and slightly higher than that reported for R-EBUS.26
Although R-EBUS was newly introduced in our depart-
ment, the incidence of complications was not higher than
that with TBB alone. We first identified the approximate
location of the lesion under fluoroscopy, followed by pre-
cise positioning with the radial ultrasound probe, which
resulted in fewer complications. Clear visualization of the
bronchial and vascular structures was possible using R-
EBUS, thereby reducing the incidence of complications
such as bleeding. Furthermore, we found that the air-
bronchus sign associated with PPLs was a significant pre-
dictive factor of a higher diagnostic yield, as reported in a
previous meta-analysis on R-EBUS.27 If the lesion is located
adjacent to the bronchus, it may be more precisely con-
firmed by ultrasound and contribute to a higher diagnostic
yield. This combined use of fluoroscopy and the radial
ultrasound probe may have contributed to the lower
Table 3 Bronchoscopic diagnosis





Diagnostic 49 (66.2) 22 (59.4) 27 (72.9)
Adenocarcinoma 43 (58.1) 19 (51.3) 24 (64.8)
Squamous cell cancer 2 (2.7) 1 (2.7) 1 (2.7)
Small cell cancer 1 (1.3) 0 (0.0) 1 (2.7)
Large cell cancer 0 (0.0) 0 (0.0) 0 (0.0)
Metastasis 3 (4.0) 2 (5.4) 1 (2.7)
Nondiagnostic 25 (33.7) 15 (40.5) 10 (37.0)
Biopsy failure 19 (25.6) 11 (29.7) 8 (21.6)
Inflammation 4 (5.4) 2 (5.4) 2 (5.4)
Granuloma 1 (1.3) 1 (2.7) 0 (0.0)
Pneumonia 1 (1.3) 1 (2.7) 0 (0.0)
R-EBUS, radial endobronchial ultrasound; TBB, transbronchial biopsy.








Hemoptysis 2 (2.7) 1 (2.7) 1 (2.7) 0.667
Pneumothorax 3 (4.0) 1 (2.7) 2 (5.4) 0.750
Fever 3 (4.0) 1 (2.7) 2 (5.4) 0.600
Desaturation
(SpO2 < 95%)
6 (8.1) 3 (8.1) 3 (8.1) 0.315
Chest pain 5 (6.7) 3 (8.1) 2 (5.4) 0.500
Respiratory failure 0 (0.0) 0 (0.0) 0 (0.0) -
Death 0 (0.0) 0 (0.0) 0 (0.0) -
Total cases 7 (9.4) 4 (10.8) 3 (8.1) 0.317
*Significant differences (P < 0.05). R-EBUS, radial endobronchial ultra-
sound; SpO2, peripheral oxygen saturation; TBB, transbronchial biopsy.
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complication rate and higher diagnostic yield observed in
the present study. Although some studies have revealed
higher complication rates during the first trimester of the
introduction of new techniques, our complication rate was
not higher than that reported in previous studies.28
The overall procedure time in both groups was longer
than that reported in a previous study.29 This was because
most patients underwent EBUS-guided transbronchial nee-
dle aspiration if mediastinal lymph nodes were noted,
adding to the procedural time. However, it is noteworthy
that the difference in the procedural time was not statisti-
cally significant between the groups. If the operator is skill-
ful in TBB, a combined technique, including R-EBUS, does
not significantly prolong the duration of the procedure.
This may also be a reason for the similar complication
rates observed between the two groups in this study. Our
findings are similar to those of a previous study by Curull
et al. which reported that R-EBUS under fluoroscopy was
safe and did not increase the total duration of the
procedure.30
To the best of our knowledge, the present study is the
first to evaluate the impact of the introduction of R-EBUS
on the diagnostic yield in a hospital where TBB has already
been implemented. We believe that this is an important
finding as it offers an alternative technique that can over-
come the limitations of TBB, which has a low diagnostic
yield. Operators who were unfamiliar with R-EBUS could
also improve the diagnostic yield when they used it in
combination with TBB.
The retrospective study design and small sample size
constitute the limitations of our study. Furthermore, the
lack of objective assessment data regarding the bronchos-
copy skills of individual operators may be a limitation.
Therefore, future prospective studies with larger sample
sizes are required to determine the impact of operator
skills on the diagnostic yield of the R-EBUS-TBB combina-
tion technique.
In conclusion, the combination of R-EBUS and TBB
resulted in a higher diagnostic yield than R-EBUS or TBB
alone. In particular, a tissue diagnosis was more likely in
pulmonary lesions with the air-bronchus sign. In institu-
tions where fluoroscopic TBB has already been
implemented, the introduction of the combination tech-
nique with R-EBUS may increase the diagnostic yield
of PPLs.
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